Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A drug combination for treating coronary heart disease angina pectoris and its preparation method

A technology for coronary heart disease angina pectoris and drugs, which is applied in drug combinations, pharmaceutical formulations, cardiovascular system diseases, etc., can solve the long-term use of calcium ion antagonists To achieve the effect of increasing coronary blood flow, improving arterial compliance, and good therapeutic effect

Inactive Publication Date: 2015-12-09
HUATUO MEDICINES CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there are many western medicines or Chinese patent medicines for the treatment of coronary heart disease and angina pectoris, but none of them can treat both symptoms and root causes. For example, although western medicine nitrates can work, they only temporarily relieve symptoms and cannot fundamentally treat them; β-receptor blockers, calcium ion The long-term use of antagonists has obvious side effects and has limitations in use
There are also some Chinese patent medicines, which only promote blood circulation and remove blood stasis, and have no therapeutic effect
The traditional Jiuxin Pill is a classic representative drug for the treatment of coronary heart disease angina pectoris. The traditional method is to use pan pills and hand-made pan pills, which has high labor intensity, low output, and is easily contaminated by microorganisms. Modern technology is also used to develop Jiuxin Pills on the market. , to overcome some traditional shortcomings, but it is found that although the traditional Jiuxin Pill and the commercially available Jiuxin Pill produced by modern technology have obvious therapeutic effects on coronary heart disease and angina pectoris, they are found to be effective in thrombus formation and platelet adhesion, blood stasis, whole blood viscosity, Plasma viscosity is reduced, and the treatment effect on coronary heart disease complications such as myocardial ischemia and electrocardiogram ST-segment changes is still insufficient.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A drug combination for treating coronary heart disease angina pectoris and its preparation method
  • A drug combination for treating coronary heart disease angina pectoris and its preparation method
  • A drug combination for treating coronary heart disease angina pectoris and its preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0027] one, The production process of this product

[0028] Calculate and feed with 500g of medicine, and take the medicine according to the following ratio: 39 parts of total saponins of ginseng stems and leaves, 16 parts of ox gall paste powder, 30 parts of artificial musk, 187 parts of pearl, 30 parts of artificial bezoar, 60 parts of borneol, 32.5 parts of toad venom, three Seven cream powder 35.1 parts, polydatin 30.3 parts, kudzu root flavonoids 40.1 parts.

[0029] A method for preparing a drug combination for treating coronary heart disease angina pectoris, comprising the following steps:

[0030] 1) Take the following proportioning raw materials: 39 parts of total saponins from ginseng stems and leaves, 16 parts of ox gall paste powder, 30 parts of artificial musk, 187 parts of pearls, 30 parts of artificial bezoar, 60 parts of borneol, 32.5 parts of toad venom, and sanqi paste powder 35.1 parts, polydatin 30.3 parts, kudzu root total flavonoids 40.1 parts;

[0031...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Toad crisp 32.5g, three -seven paste powder 35.1g, starch 70.4g.The preparation method includes the steps of crushing, sieve, molding, pills, low temperature and other steps.The combination of the invention of the drug is safe, efficient, efficient, fast, low in price, and convenient for preparation. It can be treated with coronary heart disease and angina pectoris. It can be applied to clinical rescue and can achieve healing.

Description

technical field [0001] The invention relates to a medicine, in particular to a medicine combination and a preparation method for treating coronary heart disease angina pectoris. Background technique [0002] Coronary heart disease, also known as coronary heart disease, refers to heart disease caused by coronary arteriosclerosis or functional spasm of coronary arteries leading to myocardial insufficiency, hypoxia or necrosis. When coronary heart disease angina pectoris attacks, there will be squeezing pain in the retrosternal or precordial area, which can radiate to the left shoulder and upper limbs, accompanied by pale complexion, cold sweat, rapid heart rate, and elevated blood pressure. The condition is easy to repeat, and frequent attacks can further lead to myocardial infarction, which seriously endangers human physical and mental health. [0003] At present, there are many western medicines or Chinese patent medicines for the treatment of coronary heart disease and ang...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/488A61K9/20A61P9/10A61K31/7034A61K31/045A61K35/32A61K35/413A61K35/618A61K35/65
Inventor 王守旭郑家富彭秀中赵冰王晓斌许全利杨义平何健井建芳郝学燕
Owner HUATUO MEDICINES CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products